
TOKYO: Takeda Pharmaceutical Co. plans to file for Japanese regulatory approval as early as this week for a coronavirus vaccine developed by US biotech startup Moderna Inc., informed sources said Tuesday.
The Moderna vaccine will be the third coronavirus shot to be examined for use in Japan.
JIJI Press